188 related articles for article (PubMed ID: 25041697)
1. What the devil is in your phytomedicine? Exploring species substitution in Harpagophytum through chemometric modeling of 1H-NMR and UHPLC-MS datasets.
Mncwangi NP; Viljoen AM; Zhao J; Vermaak I; Chen W; Khan I
Phytochemistry; 2014 Oct; 106():104-115. PubMed ID: 25041697
[TBL] [Abstract][Full Text] [Related]
2. Harpagoside Content in Devil's Claw Extracts.
Kondamudi N; Turner MW; McDougal OM
Nat Prod Commun; 2016 Sep; 11(9):1215-1216. PubMed ID: 30807002
[TBL] [Abstract][Full Text] [Related]
3. Devil's Claw-a review of the ethnobotany, phytochemistry and biological activity of Harpagophytum procumbens.
Mncwangi N; Chen W; Vermaak I; Viljoen AM; Gericke N
J Ethnopharmacol; 2012 Oct; 143(3):755-71. PubMed ID: 22940241
[TBL] [Abstract][Full Text] [Related]
4. Effect of the major glycosides of Harpagophytum procumbens (Devil's Claw) on epidermal cyclooxygenase-2 (COX-2) in vitro.
Abdelouahab N; Heard C
J Nat Prod; 2008 May; 71(5):746-9. PubMed ID: 18412394
[TBL] [Abstract][Full Text] [Related]
5. LC-DAD-MS/SPE-NMR hyphenation. A tool for the analysis of pharmaceutically used plant extracts: identification of isobaric iridoid glycoside regioisomers from Harpagophytum procumbens.
Seger C; Godejohann M; Tseng LH; Spraul M; Girtler A; Sturm S; Stuppner H
Anal Chem; 2005 Feb; 77(3):878-85. PubMed ID: 15679357
[TBL] [Abstract][Full Text] [Related]
6. New and known iridoid- and phenylethanoid glycosides from Harpagophytum procumbens and their in vitro inhibition of human leukocyte elastase.
Boje K; Lechtenberg M; Nahrstedt A
Planta Med; 2003 Sep; 69(9):820-5. PubMed ID: 14598207
[TBL] [Abstract][Full Text] [Related]
7. An analytical study, anti-inflammatory and analgesic effects of Harpagophytum procumbens and Harpagophytum zeyheri.
Baghdikian B; Lanhers MC; Fleurentin J; Ollivier E; Maillard C; Balansard G; Mortier F
Planta Med; 1997 Apr; 63(2):171-6. PubMed ID: 9140234
[TBL] [Abstract][Full Text] [Related]
8. Toxicology studies of aqueous-alcohol extracts of Harpagophytum procumbens subsp. procumbens (Burch.) DC.Ex Meisn. (Pedaliaceae) in female and male rats.
Joshi K; Parrish A; Grunz-Borgmann EA; Gerkovich M; Folk WR
BMC Complement Med Ther; 2020 Jan; 20(1):9. PubMed ID: 32020872
[TBL] [Abstract][Full Text] [Related]
9. The Fight against Infection and Pain: Devil's Claw (
Gxaba N; Manganyi MC
Molecules; 2022 Jun; 27(11):. PubMed ID: 35684573
[No Abstract] [Full Text] [Related]
10. Effects of Devil's Claw (Harpagophytum procumbens) on the multidrug transporter ABCB1/P-glycoprotein.
Romiti N; Tramonti G; Corti A; Chieli E
Phytomedicine; 2009 Dec; 16(12):1095-100. PubMed ID: 19577448
[TBL] [Abstract][Full Text] [Related]
11. Quality control of Harpagophytum procumbens and its related phytopharmaceutical products by means of NIR-FT-Raman spectroscopy.
Baranska M; Schulz H; Siuda R; Strehle MA; Rösch P; Popp J; Joubert E; Manley M
Biopolymers; 2005 Jan; 77(1):1-8. PubMed ID: 15558669
[TBL] [Abstract][Full Text] [Related]
12. Analysis and stability of the constituents of Curcuma longa and Harpagophytum procumbens tinctures by HPLC-DAD and HPLC-ESI-MS.
Karioti A; Fani E; Vincieri FF; Bilia AR
J Pharm Biomed Anal; 2011 Jun; 55(3):479-86. PubMed ID: 21420820
[TBL] [Abstract][Full Text] [Related]
13. DNA Barcode Authentication of Devil's Claw Herbal Dietary Supplements.
Diaz-Silveira GL; Deutsch J; Little DP
Plants (Basel); 2021 Sep; 10(10):. PubMed ID: 34685813
[TBL] [Abstract][Full Text] [Related]
14. Harpagoside: from Kalahari Desert to pharmacy shelf.
Georgiev MI; Ivanovska N; Alipieva K; Dimitrova P; Verpoorte R
Phytochemistry; 2013 Aug; 92():8-15. PubMed ID: 23642455
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of iNOS expression in rat mesangial cells by special extracts of Harpagophytum procumbens derives from harpagoside-dependent and independent effects.
Kaszkin M; Beck KF; Koch E; Erdelmeier C; Kusch S; Pfeilschifter J; Loew D
Phytomedicine; 2004 Nov; 11(7-8):585-95. PubMed ID: 15636171
[TBL] [Abstract][Full Text] [Related]
16. Comparison between HPLC and HPTLC-densitometry for the determination of harpagoside from Harpagophytum procumbens CO(2)-extracts.
Günther M; Schmidt PC
J Pharm Biomed Anal; 2005 Apr; 37(4):817-21. PubMed ID: 15797807
[TBL] [Abstract][Full Text] [Related]
17. Identification of major and minor constituents of Harpagophytum procumbens (Devil's claw) using HPLC-SPE-NMR and HPLC-ESIMS/APCIMS.
Clarkson C; Staerk D; Hansen SH; Smith PJ; Jaroszewski JW
J Nat Prod; 2006 Sep; 69(9):1280-8. PubMed ID: 16989520
[TBL] [Abstract][Full Text] [Related]
18. Rapid measurement and evaluation of the effect of drying conditions on harpagoside content in Harpagophytum procumbens (devil's claw) root.
Joubert E; Manley M; Gray BR; Schulz H
J Agric Food Chem; 2005 May; 53(9):3493-502. PubMed ID: 15853393
[TBL] [Abstract][Full Text] [Related]
19. Formation of nitrogen-containing metabolites from the main iridoids of Harpagophytum procumbens and H. zeyheri by human intestinal bacteria.
Baghdikian B; Guiraud-Dauriac H; Ollivier E; N'Guyen A; Dumenil G; Balansard G
Planta Med; 1999 Mar; 65(2):164-6. PubMed ID: 10193209
[TBL] [Abstract][Full Text] [Related]
20. Iridoid glycosides from Harpagophytum procumbens D.C. (devil's claw).
Qi J; Chen JJ; Cheng ZH; Zhou JH; Yu BY; Qiu SX
Phytochemistry; 2006 Jul; 67(13):1372-7. PubMed ID: 16857222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
